Biocon (BIOCON.NS) Financial Analysis & Valuation | Quarter Chart
Biocon (BIOCON.NS)
BIOCON.NSPrice: $4.41
Fair Value: 🔒
🔒score
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and... more
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical an... more
Description
Shares
| Market Cap | $6.03B | Exchange | NSE |
| Sector | Healthcare | Industry | Biotechnology |
| Country | IN | CEO | Shreehas Pradeep Tambe MTech |
| IPO Date | 2004-04-07 | CAGR | 0.17% |
| Employees | 16,315 | Website | www.biocon.com |
| Div. Yield | 0.11% | Payout Ratio | 0.17% |
| Buy Back Yield | — | Total Yield | 0.11% |
BIOCON.NS chart loading...
Fundamentals
Technicals
| Enterprise Value | $697.33B | P/E Ratio | 129.18 |
| Forward P/E | 35.34 | PEG Ratio | -2.04 |
| P/S Ratio | 3.28 | P/B Ratio | 1.9 |
| P/CF Ratio | 80.58 | P/FCF Ratio | -965.97 |
| EPS | $0.03 | EPS Growth 1Y | -67.18% |
| EPS Growth 3Y | -28.24% | EPS Growth 5Y | -55.25% |
| Revenue Growth 1Y | 10.7% | Gross Margin | 0.5% |
| Operating Margin | 0.17% | Profit Margin | 0.02% |
| ROE | 0.01% | ROA | 0.01% |
| ROCE | 0.06% | Current Ratio | 1.22 |
| Quick Ratio | 0.79 | Cash Ratio | 0.23 |
| Debt/Equity | 0.45 | Interest Coverage | 2.88 |
| Altman Z Score | 1.71 | Piotroski Score | 7 |